- Home
- PRIM vs LEGN Comparison
PRIM vs LEGN Comparison
Compare PRIM & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRIM
- LEGN
- Stock Information
- Founded
- PRIM 1960
- LEGN 2014
- Country
- PRIM United States
- LEGN United States
- Employees
- PRIM N/A
- LEGN N/A
- Industry
- PRIM Water Sewer Pipeline Comm & Power Line Construction
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- PRIM Industrials
- LEGN Health Care
- Exchange
- PRIM Nasdaq
- LEGN Nasdaq
- Market Cap
- PRIM 6.6B
- LEGN 6.3B
- IPO Year
- PRIM N/A
- LEGN 2020
- Fundamental
- Price
- PRIM $144.26
- LEGN $32.13
- Analyst Decision
- PRIM Strong Buy
- LEGN Strong Buy
- Analyst Count
- PRIM 14
- LEGN 12
- Target Price
- PRIM $131.46
- LEGN $70.82
- AVG Volume (30 Days)
- PRIM 747.8K
- LEGN 1.5M
- Earning Date
- PRIM 11-03-2025
- LEGN 11-12-2025
- Dividend Yield
- PRIM 0.22%
- LEGN N/A
- EPS Growth
- PRIM 55.06
- LEGN N/A
- EPS
- PRIM 4.40
- LEGN N/A
- Revenue
- PRIM $6,929,274,000.00
- LEGN $796,838,000.00
- Revenue This Year
- PRIM $13.51
- LEGN $68.68
- Revenue Next Year
- PRIM $8.61
- LEGN $48.49
- P/E Ratio
- PRIM $32.79
- LEGN N/A
- Revenue Growth
- PRIM 15.08
- LEGN 74.75
- 52 Week Low
- PRIM $49.10
- LEGN $27.34
- 52 Week High
- PRIM $146.16
- LEGN $47.79
- Technical
- Relative Strength Index (RSI)
- PRIM 62.15
- LEGN 44.89
- Support Level
- PRIM $139.26
- LEGN $31.44
- Resistance Level
- PRIM $145.00
- LEGN $33.09
- Average True Range (ATR)
- PRIM 6.03
- LEGN 1.41
- MACD
- PRIM -0.16
- LEGN 0.10
- Stochastic Oscillator
- PRIM 89.92
- LEGN 33.75
About PRIM Primoris Services Corporation
Primoris Services Corp is a provider of infrastructure services operating mainly in the United States and Canada. It provides a wide range of construction services, maintenance, replacement, fabrication and engineering services to a diversified base of customers. The reportable segments are the Utilities segment and the Energy segment. The Utilities segment operates in a range of services, including the installation and maintenance of new and existing natural gas and electric utility distribution and transmission systems, and communication systems. The Energy segment operates in a range of services that include engineering, procurement, and construction, retrofits, highway and bridge construction, demolition, site work, outages, pipeline construction and maintenance, and others.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.